Comerica Bank’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-19
Closed -$358 3870
2023
Q3
$358 Buy
+19
New +$215 ﹤0.01% 3736
2014
Q2
Sell
-670
Closed -$221K 2233
2014
Q1
$221K Buy
+670
New +$226K ﹤0.01% 2125

Comerica Bank's ICPT Position: Q4 2023 in Review

Comerica Bank sold out of Intercept Pharmaceuticals, Inc. (ICPT) in Q4 2023, closing a stake of 19 shares — an estimated $358 sold.

Comerica Bank first reported a position in ICPT in Q1 2014 and held it in 2 quarters. The position peaked at $221K in Q1 2014. 0 funds tracked by Wall St. Rank hold ICPT as of Q4 2023.

  • Comerica Bank reported no remaining Intercept Pharmaceuticals, Inc. position as of Q4 2023 after selling out during the quarter.
  • Comerica Bank sold 19 Intercept Pharmaceuticals, Inc. shares in Q4 2023, an estimated $358.
  • Comerica Bank first reported a position in Intercept Pharmaceuticals, Inc. in Q1 2014 and held it in 2 quarters.
  • Comerica Bank's Intercept Pharmaceuticals, Inc. position peaked at $221K in Q1 2014.
  • 0 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q4 2023.

Based on Comerica Bank's 13F filing for Q4 2023, filed 14 Feb 2024.